J2 Global 2021 Annual Diversity Report
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
J2 GLOBAL, INC
SECURITIES AND EXCHANGE COMMISSION FORM 10-K Annual report pursuant to section 13 and 15(d) Filing Date: 2019-03-01 | Period of Report: 2018-12-31 SEC Accession No. 0001084048-19-000002 (HTML Version on secdatabase.com) FILER J2 GLOBAL, INC. Mailing Address Business Address 6922 HOLLYWOOD BLVD 6922 HOLLYWOOD BLVD CIK:1084048| IRS No.: 471053457 | Fiscal Year End: 1231 LEGAL DEPT - 5TH FLOOR LEGAL DEPT - 5TH FLOOR Type: 10-K | Act: 34 | File No.: 000-25965 | Film No.: 19650407 LOS ANGELES CA 90028 LOS ANGELES CA 90028 SIC: 4822 Telegraph & other message communications 3238609200 Copyright © 2019 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-25965 j2 GLOBAL, INC. (Exact name of registrant as specified in its charter) Delaware 47-1053457 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 6922 Hollywood Boulevard, Suite 500, Los Angeles, California 90028, (323) 860-9200 (Address and telephone number of principal executive offices) Securities registered pursuant to Section 12(b) of the Act: None Securities registered pursuant to Section 12(g) of the Act: Common Stock, $0.01 par value (Title of class) Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. -
Capstone Healthcare IT M&A Report Q1 2017
HEALTHCARE INFORMATION TECHNOLOGY Q1 2017 CONTACTS MERGERS AND ACQUISITIONS OVERVIEW David DeSimone The Healthcare Information Technology (HCIT) sector continued to be extremely attractive Director for mergers and acquisitions in 2016 with average EV/EBITDA multiples of 23.9x and (617) 619‐3324 average EV/Revenue multiples of 5.3x. While the number of transactions fell slightly from [email protected] the record high set in 2015, the average transaction value increased from $95.5 to $149.4 million. In part, this was due to Quintiles’ blockbuster acquisition of IMS Health in May, David Michaels which closed at $13.2 billion. Buyers spent a total of approximately $25.8 billion on Managing Director disclosed acquisitions in 2016 compared to $7.2 billion in 2015. (858) 926‐5950 [email protected] The HCIT market has profited over the past 2016 Buyer Breakdown: HCIT several years from the downstream demand of healthcare services. As more Americans seek medical attention (due to both the growing geriatric population and new STRATEGIC 21.4% 24.9% enrollees from the Affordable Care Act), Public companies are increasingly seeking digital Private solutions to improve operating efficiencies, 8.7% cut costs and assist in regulatory FINANCIAL compliances. Demand for data storage, Direct cloud technology, analytics, interoperability, Add‐on 45.1% cybersecurity, smart medical devices and electronic health record (EHR) management will help drive industry growth in 2017. Consumerization is also driving HCIT M&A activity. Individuals have become accustomed to paying for many of their healthcare expenses out‐of‐pocket and seek ways to empower their purchasing decisions through education and personalized care. -
J2 Global, Inc
J2 GLOBAL, INC. FORM 10-K (Annual Report) Filed 03/01/13 for the Period Ending 12/31/12 Address 6922 HOLLYWOOD BLVD LEGAL DEPT - 5TH FLOOR LOS ANGELES, CA 90028 Telephone 3238609200 CIK 0001084048 Symbol JCOM SIC Code 4822 - Telegraph and Other Message Communications Industry Communications Services Sector Services Fiscal Year 12/31 http://www.edgar-online.com © Copyright 2013, EDGAR Online, Inc. All Rights Reserved. Distribution and use of this document restricted under EDGAR Online, Inc. Terms of Use. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2012 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-25965 j2 GLOBAL, INC. (Exact name of registrant as specified in its charter) Delaware 51-0371142 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 6922 Hollywood Boulevard, Suite 500, Los Angeles, California 90028, (323) 860-9200 (Address and telephone number of principal executive offices) Securities registered pursuant to Section 12(b) of the Act: None Securities registered pursuant to Section 12(g) of the Act: Common Stock, $0.01 par value (Title of class) Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. -
151650-Medadnews-Aug
THE MAGAZINE OF PHARMACEUTICAL BUSINESS AND MARKETING • MEDADNEWS.COM • AUGUST 2013 • VOLUME 32 NUMBER 8 • $25 IN THIS ISSUE: SPECIAL REPORT 12 ONCOLOGY FIRST YEAR Oncology drugs continue to be a major focus for pharmaceutical and biotechnology companies, AFTER LAUNCH and the ASCO meeting highlighted what oncologists are most anticipating. The new medicines introduced to the U.S. market during 2011 include a variety of blockbuster products that will help restore growth for the pharmaceutical industry. By Andrew Humphreys [email protected] or the global pharma arena, 2012 is noted as the year of the patent and RBV for 48 weeks. T ose new treatment regimens incorporating HCV clif , with roughly $38 billion in prescription drug sales lost due to protease inhibitors of er substantially increased sustained viral response rates the exclusivity expiration of some of the all-time best sellers, includ- – and in many instances shorter treatment durations – for patients with geno- ing Lipitor and Plavix. As a result, total worldwide Rx brand sales type 1 HCV infection, versus peg-IFN and RBV alone. uncharacteristically decreased year over year. But overall global sales Incivek attained rapid acceptance in the United States for treating patients Fgrowth for branded prescription drugs is expected to slightly increase in 2013, with genotype 1 HCV infection. Vertex reported total sales (for the United and is anticipated to gain better traction and increase by several percentage States and Canada) of $950.9 million in 2011, increasing to $1.16 billion points during each of the next few years thereafter. Helping spur this sales during 2012. -
View Annual Report
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-25965 J2 GLOBAL, INC. (Exact name of registrant as specified in its charter) Delaware 47-1053457 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 700 S. Flower Street, 15th Floor, Los Angeles, California 90017, (323) 860-9200 (Address and telephone number of principal executive offices) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value JCOM Nasdaq Stock Market LLC Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes x No o Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes o No x Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. -
Rank1/200) (Rank: 6/200) Rank Company Number Avg
493 Total International Students On Campus Spring 2103 272 Total International COB Students Spring 2013 55% of Total International Student Population 18% of COB Population Computer Systems Analyst Management Analysts (Rank1/200) (Rank: 6/200) Rank Company Number Avg. Salary Rank 1 Infosys Limited 10,154 $73,412 1 2 Cognizant Technology Solutions 1,761 $67,051 2 3 IBM 1,217 $85,232 3 4 Deloitte Consulting 1,111 $79,778 4 5 Satyam Computer Services 1,076 $72,356 5 6 UST Global 1,013 $63,886 6 7 HCL Technologies America 977 $73,009 7 8 Patni Americas 820 $70,699 8 9 Wipro 785 $82,443 9 10 Hexaware Technologies 610 $63,204 10 11 Deloitte Touche 549 $81,179 11 12 Accenture 491 $79,527 12 13 Tata Consultancy Services 381 $65,010 13 14 Mphasis 367 $66,044 14 15 Synechron 358 $77,189 15 16 Capgemini Financial Services 318 $78,030 16 17 Virgo 291 $60,227 17 18 Hewlett Packard 272 $96,771 18 19 Diaspark 270 $64,728 19 20 Yash Technologies 269 $55,205 20 21 Advent Global Solutions 247 $62,220 21 22 RS Software India 243 $67,253 22 23 Infosys Limited 241 $78,296 23 24 Persistent Systems 240 $71,556 24 25 Reliable Software Resources 232 $60,521 25 26 Larsen Toubro Infotech 231 $65,177 26 27 kforce 225 $90,304 27 28 Ernst Young 217 $89,948 28 29 Pricewaterhousecoopers 208 $66,478 29 30 Compunnel Software Group 206 $76,062 30 31 Polaris Software Lab 204 $69,457 31 32 Tech Mahindra americas 204 $64,965 32 33 Horizon Technologies 199 $61,330 33 34 SAP America 198 $102,811 34 35 Orian Engineersorporated 197 $62,835 35 36 Oracle 195 $93,968 36 37 Syntel -
2008 Umaine News Press Releases
The University of Maine DigitalCommons@UMaine General University of Maine Publications University of Maine Publications 2008 2008 UMaine News Press Releases Division of Marketing and Communications Joe Carr University of Maine George Manlove University of Maine Dan Cashman University of Maine Margaret Nagle University of Maine Follow this and additional works at: https://digitalcommons.library.umaine.edu/univ_publications Part of the Higher Education Commons, and the History Commons Repository Citation Division of Marketing and Communications; Carr, Joe; Manlove, George; Cashman, Dan; and Nagle, Margaret, "2008 UMaine News Press Releases" (2008). General University of Maine Publications. 1092. https://digitalcommons.library.umaine.edu/univ_publications/1092 This Monograph is brought to you for free and open access by DigitalCommons@UMaine. It has been accepted for inclusion in General University of Maine Publications by an authorized administrator of DigitalCommons@UMaine. For more information, please contact [email protected]. UMaine News Press Releases from Word Press XML export 2008 Williams Appointed to University of Maine Foundation Post 07 Jan 2008 Contact: Contact: Amos Orcutt, University of Maine Foundation President/CEO, 207 581-5100 ORONO -- Amos Orcutt, president/CEO of the University of Maine Foundation, has announced the appointment of Daniel B. Williams as planned giving officer. Williams, who earned both a bachelor's degree and a master's degree from UMaine, returns to his alma mater having accumulated a great deal of experience relevant to his new position. Since 2006, Williams has served as foundation president and director of development for Eastern Maine Community College in Bangor. In that role, he was responsible for all institutional fundraising including planned giving, annual and endowed scholarships, in-kind gifts, annual campaign and capital projects. -
J2 Global Annual Report 2021
J2 Global Annual Report 2021 Form 10-K (NASDAQ:JCOM) Published: March 1st, 2021 PDF generated by stocklight.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-25965 J2 GLOBAL, INC. (Exact name of registrant as specified in its charter) Delaware 47-1053457 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 700 S. Flower Street, 15th Floor, Los Angeles, California 90017, (323) 860-9200 (Address and telephone number of principal executive offices) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value JCOM Nasdaq Stock Market LLC Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐ Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. -
Core Investor Presentation August 11, 2020 Safe Harbor for Forward-Looking Statements
Core Investor Presentation August 11, 2020 Safe Harbor for Forward-Looking Statements Certain statements in this presentation are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, particularly those regarding our 2020 Financial Guidance. Such forward-looking statements are subject to numerous assumptions, risks and uncertainties that could cause actual results to differ materially from those described in those statements. Readers should carefully review the Risk Factors slide of this presentation. These forward-looking statements are based on management’s expectations or beliefs as of August 11, 2020 as well as those set forth in our Annual Report on Form 10-K filed by us on March 2, 2020 with the Securities and Exchange Commission (“SEC”) and the other reports we file from time to time with the SEC. We undertake no obligation to revise or publicly release any updates to such statements based on future information or actual results. Such forward-looking statements address the following subjects, among others: • Future operating results • Ability to acquire businesses on acceptable terms and integrate and recognize synergies from acquired businesses • Deployment of cash and investment balances to grow the company • Subscriber growth, retention, usage levels and average revenue per account • Cloud service and digital media growth and continued demand for fax services • International growth • New products, services, features and technologies • Corporate spending including stock repurchases • Intellectual property and related licensing revenues • Liquidity and ability to repay or refinance indebtedness • Systems capacity, coverage, reliability and security • Regulatory developments and taxes All information in this presentation speaks as of August 11, 2020 and any redistribution or rebroadcast of this presentation after that date is not intended and will not be construed as updating or confirming such information. -
J2 Global, Inc. Named As One of 50 Best Small Companies in America by Forbes
November 7, 2013 j2 Global, Inc. Named as One of 50 Best Small Companies in America by Forbes The Recognition Comes Just After InformationWeek Names j2 Global Among the Top Technology Companies for the Third Straight Year LOS ANGELES, CA -- (Marketwired) -- 11/07/13 -- j2 Global, Inc. (NASDAQ: JCOM), a provider of business cloud and digital ® media services, today announced that the company has once again been named to the Forbes list of 100 Best Small Companies in America™, ranking in the top 50 of all companies. Forbes key criteria in awarding the honor is a company that consistently shows "...strong sales and earnings growth." In conjunction with announcing the top 100 companies of 2013, Forbes features j2 in a story in its October issue titled "Darwin's Digital Darlings: How These Web 1.0 Companies Survived And Thrived." The Forbes award is the second major industry honor j2 has received in as many months -- earning a place in September on the InformationWeek® 500™, a list of leading technology companies in the US. ® ® ® The brands of j2 and its subsidiaries include eFax (online fax), eVoice (virtual voice), KeepItSafe (online backup), ® ® ® Onebox (unified communications), Campaigner (email marketing), FuseMail (hosted email) and Ziff Davis (digital media). "Successfully serving the cloud communication and digital media needs of our customers is truly a global effort and the result of a hard-working, dedicated group of talented individuals around the world," said j2 CEO Hemi Zucker. "Our cloud services teams work tirelessly to help businesses of all sizes that count on j2 every day for mission-critical communication services, and our digital media teams help keep consumers in the know on the best products and services on the market. -
Vivek Shah, CEO of Ziff Davis, a J2 Global® Division, Elected Chairman of the Interactive Advertising Bureau (IAB) Board of Directors
March 11, 2014 Vivek Shah, CEO of Ziff Davis, a j2 Global® Division, Elected Chairman of the Interactive Advertising Bureau (IAB) Board of Directors With more than 600 leading media and technology companies, IAB membership sells 86% of the online advertising in the US NEW YORK--(BUSINESS WIRE)-- Ziff Davis, the digital media company with leadership positions in the technology, gaming/entertainment and men's lifestyle verticals, and a division of j2 Global, Inc (NASDAQ: JCOM), today announced that the Interactive Advertising Bureau (IAB) has elected Vivek Shah, CEO of Ziff Davis, as the new Chairman of the IAB Board of Directors. "I'd like to congratulate Vivek on being elected Chairman of the IAB," said Hemi Zucker, j2 Global's CEO. "His vision, passion, and experience will be invaluable assets in the interactive advertising industry's important educational, standardization, and advocacy efforts." As Chairman, Shah will help steer the IAB in the pursuit of its five key objectives — The Trustworthy Digital Marketing Supply Chain, Making Measurement Make Sense, Publisher Transformation, Building Brands Digitally, and Moving Mobile Mainstream. "2014 marks the 20th anniversary of the internet ad banner," said Shah in accepting the Chairmanship. "In the intervening 20 years, we've come very far in so many ways: the number of internet users worldwide has grown to over 2.5 billion or about 35% of the world's population; we've created standards around units, impressions and general terms & conditions; we've deployed a self-regulatory program for online behavioral advertising; and we've seen the industry grow to close to $40 billion in revenues in the US." Shah joined Ziff Davis in 2010 as the company's Chief Executive Officer and led the sale of the company to j2 Global in November 2012. -
J2 GLOBAL, INC. (Exact Name of Registrant As Specified in Its Charter) Delaware 47-1053457 (State Or Other Jurisdiction of Incorporation Or Organization) (I.R.S
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0-25965 j2 GLOBAL, INC. (Exact name of registrant as specified in its charter) Delaware 47-1053457 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 6922 Hollywood Boulevard, Suite 500, Los Angeles, California 90028, (323) 860-9200 (Address and telephone number of principal executive offices) Securities registered pursuant to Section 12(b) of the Act: None Securities registered pursuant to Section 12(g) of the Act: Common Stock, $0.01 par value (Title of class) Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes No Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).